Candel Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Candel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Candel Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Candel Therapeutics by Goldman Sachs Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $113k | 18k | 6.20 |
2022-06-30 | $33k | 10k | 3.29 |
2022-03-31 | $53k | 11k | 5.04 |
2021-12-31 | $83k | 11k | 7.84 |